ONCSQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ONCSQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
OncoSec Medical has the Momentum Rank of 0.
For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.
Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.
For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of OncoSec Medical's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert J Delaversano | officer: Principal Accounting Officer | 217 W. MAIN STREET, SOMERVILLE NJ 08876 |
Spahr Stephany Foster | director | C/O ONCOSEC MEDICAL, 24 NORTH MAIN STREET, PENNINGTON NJ 08534 |
Robert H. Arch | officer: President and CEO | C/O ONCOSEC MEDICAL INCORPORATED, 24 NORTH MAIN STREET, PENNINGTON NJ 08534 |
George Chi | officer: Chief Financial Officer | 9620 MEDICAL CENTER DRIVE, SUITE 300, ROCKVILLE MD 20850 |
Lin Shi | director | 24 NORTH MAIN STREET, PENNINGTON NJ 08534-2218 |
Margaret Dalesandro | director | ONCOSEC MEDICAL INCORPORATED, 24 NORTH MAIN STREET, PENNINGTON NJ 08534 |
Yuhang Zhao | director | 6 HORTON DR., CHESTER NJ 07930 |
Brian A Leuthner | officer: Chief Operating Officer | 200 CONNELL DRIVE, SUITE 1600, BERKELEY HEIGHTS NJ 07922 |
Daniel J. O'connor | director | C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022 |
China Grand Pharmaceutical & Healthcare Holdings Ltd | 10 percent owner, other: See Remarks | UNIT 3302, 33/F, THE CENTER, 99 QUEEN'S ROAD, CENTRAL K3 000000 |
Alpha Holdings, Inc. | director, 10 percent owner | GANGNAM-GU APGUJEONG-RO 62-GIL 17-10, SEOUL M5 06016 |
Kellie Malloy Foerter | officer: Chief Operating Officer | C/O ONCOSEC MEDICAL INCORPORATED, 24 N. MAIN STREET, PENNINGTON NJ 08534-2218 |
Herbert Kim Lyerly | director | C/O ONCOSEC MEDICAL INCORPORATED, 24 NORTH MAIN STREET, PENNINGTON NJ 08534-2218 |
Chao Zhou | director | UNIT 3302, 33/F, THE CENTER, 99 QUEEN'S ROAD, CENTRAL K3 000000 |
Grand Decade Developments Ltd | 10 percent owner, other: See Remarks | UNIT 3302, 33/F, THE CENTER, 99 QUEEN'S ROAD, CENTRAL K3 000000 |
From GuruFocus
By PRNewswire PRNewswire • 05-18-2023
By PRNewswire PRNewswire • 04-29-2022
By PRNewswire PRNewswire • 07-12-2022
By PRNewswire PRNewswire • 07-06-2021
By PRNewswire PRNewswire • 07-26-2021
By PRNewswire PRNewswire • 11-02-2021
By PRNewswire PRNewswire • 10-20-2021
By PRNewswire PRNewswire • 03-01-2023
By PRNewswire PRNewswire • 07-02-2022
By PRNewswire PRNewswire • 12-17-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.